Ankur Varma, MBBS

Full Member

Research Program:

Cancer Therapeutics

Faculty Rank:

Associate Professor

Campus:

University of Arkansas for Medical Sciences

College:

College of Medicine

Department:

Medicine

Cancer Research Interest

Disease Site Focus: Leukemia/ Lymphoma, Hematologic Malignancies
Research Focus Area: Treatment, Diagnosis/ Prognosis
Type of Research: Clinical, Translational
Research Keywords: AML, ALL, CML, CLL, MDS
Research Interest Statement: My cancer research focuses on improving treatment outcomes for hematologic cancers, particularly leukemia, lymphoma, and myelodysplastic syndromes (MDS). I am deeply interested in the role of stem cell transplants in treating these conditions, aiming to optimize transplant procedures and reduce complications. Additionally, I explore novel therapeutic approaches to enhance the effectiveness of stem cell transplants and improve long-term survival for patients battling these aggressive blood cancers.

“MYELOMATCH, Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI myeloMATCH Clinical Trials” (NCT05564390)
“Expanded Access Protocol (EAP) for Patients Receiving Lisocabtagene Maraleucel that is Nonconforming for Commercial Release” (NCT04400591)

Thalambedu N, Mohan Lal B, Harbaugh B, [et al., including Varma A]. Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances. Cancers. 2025 17(3). PMID: 39941875. PMCID: PMC11816122.
Fugere T, Baltz A, Mukherjee A, [et al., including Varma A]. Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity. Cancers. 2023 15(21). PMID: 37958323. PMCID: PMC10647774.
Gannamani V, Varma A, Nathan S, Ustun C. Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient. Transplant immunology. 2023 76:101742. PMID: 36372142.
Baranwal A, Byun J, Ritz E, [et al., including Varma A]. Myeloablative TBI is associated with increased risk of pulmonary GVHD in patients undergoing allogeneic hematopoietic stem cell transplant. Bone marrow transplantation. 2022 57(10):1632-1634. PMID: 35970875.
Varma A, Kosuri S, Ustun C, [et al.]. COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter. Leukemia. 2020 34(10):2809-2812. PMID: 32801310. PMCID: PMC7427757.